Siemens Healthineers and NYU Langone Health have entered a five-year strategic alliance providing advanced diagnostic imaging across the NYU Langone Health network in Manhattan, Brooklyn and Long Island. The agreement covers the purchase of magnetic resonance (MR), computed tomography (CT), molecular imaging, X-ray, products, ultrasound, angiography and C arms.
The parties have also signed a five-year, $100 million integrated service management agreement to deliver vendor-agnostic routine service after business hours. Included are a dedicated service manager and a team of engineers for rapid response to critical equipment issues.
The relationship between Siemens Healthineers and NYU Langone spans two decades and has produced multiple firsts in clinical use of MR, including motion insensitive body imaging and AI-driven image reconstruction.
“Our team is constantly searching for ways to maximize productivity and improve patient care,” said Michael P. Recht, MD, chair of the Department of Radiology at NYU Langone Health, and the Louis Marx Professor of Radiology. “We look forward to working closely with Siemens Healthineers in a long-term partnership in pursuit of these core goals.”
Added John Kowal, president and head of the Americas at Siemens Healthineers: “We believe that patients deserve not only the best available healthcare technology, but that those systems should be working as intended to provide convenient and efficient care. These agreements help to ensure both.”
Media contact
Julie Gibson
Phone: +1 927 929 5779
Email: julie.gibson@siemens-healthineers.com
Visit the Siemens Healthineers Press Center.
Subscribe to our “Medtech matters” newsletter on LinkedIn.
Siemens Healthineers pioneers breakthroughs in healthcare. For everyone. Everywhere. Sustainably. The company is a global provider of healthcare equipment, solutions and services, with activities in more than 180 countries and direct representation in more than 70. The group comprises Siemens Healthineers AG, listed as SHL in Frankfurt, Germany, and its subsidiaries. As a leading medical technology company, Siemens Healthineers is committed to improving access to healthcare for underserved communities worldwide and is striving to overcome the most threatening diseases. The company is principally active in the areas of imaging, diagnostics, cancer care and minimally invasive therapies, augmented by digital technology and artificial intelligence. In fiscal 2025, which ended on September 30, 2025, Siemens Healthineers had approximately 74,000 employees worldwide and generated revenue of around €23.4 billion. Further information is available at siemens-healthineers.com.
